Research supported by Starr Cancer Consortium awards is reported in the following publications. The Starr Cancer Consortium is funded by the Starr Foundation.
Chemical reporters for exploring protein acylation.
The tumor virus landscape of AIDS-related lymphomas.
A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer.
MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.
Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth.
Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma.
The microRNA-17-92 family of microRNA clusters in development and disease.
CDK4/6 inhibitor PD 0332991 sensitizes acute myeloid leukemia to cytarabine-mediated cytotoxicity.
Organoid models of human and mouse ductal pancreatic cancer.
Extracellular metabolic energetics can promote cancer progression.
Integrative clinical genomics of advanced prostate cancer.
Non-coding RNA Generated following Lariat Debranching Mediates Targeting of AID to DNA.
Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors.